Botulinum Toxin Type A(Botox®)
Sponsors
Medy-Tox, Hugel
Conditions
Essential BlepharospasmOther Infantile Cerebral PalsySkin AgingSpasticityStroke
Phase 3
Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
CompletedNCT01237977
Start: 2009-11-23End: 2010-09-30Updated: 2019-03-28
Phase III Clinical Trial of Botulax® to Treat Children With Cerebral Palsy
CompletedNCT01787344
Start: 2012-03-31End: 2014-08-31Updated: 2015-05-04
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of Hugeltox Inj. in Essential Blepharospasm
CompletedNCT01791881
Start: 2008-04-30End: 2009-07-31Updated: 2013-02-15
To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines
CompletedNCT01791920
Start: 2011-08-31End: 2012-03-31Updated: 2022-04-15
Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity
CompletedNCT01915459
Start: 2013-06-30End: 2014-07-31Updated: 2015-05-04